{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:39:33Z","timestamp":1773297573232,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1080\/14653240802251507","type":"journal-article","created":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T17:02:28Z","timestamp":1215709348000},"page":"443-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The history and future prospective of haplo-identical stem cell transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"R.","family":"Handgretinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/14653240802251507_bib0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-199510270-00003","article-title":"Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor","volume":"60","author":"Beatty","year":"1995","journal-title":"Transplantation"},{"key":"10.1080\/14653240802251507_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1704865","article-title":"How to improve the search for an unrelated haematopoietic stem cell donor","volume":"35","author":"Heemskerk","year":"2005","journal-title":"Faster is better than more! Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1705787","article-title":"The probability of identifying a 10\/10 HLA allele-matched unrelated donor is highly predictable","volume":"40","author":"Tiercy","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","article-title":"Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia","volume":"1","author":"Powles","year":"1983","journal-title":"Lancet"},{"key":"10.1080\/14653240802251507_bib0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240802251507_bib0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240802251507_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(84)91277-7","article-title":"Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow","volume":"1","author":"Friedrich","year":"1984","journal-title":"Lancet"},{"key":"10.1080\/14653240802251507_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1704391","article-title":"Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients","volume":"33","author":"Mehta","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0045","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood.V89.10.3864","article-title":"Use of partially mismatched related donors extends access to allogeneic marrow transplant","volume":"89","author":"Henslee-Downey","year":"1997","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00062752-199704060-00010","article-title":"Use of stem cells from mismatched related donors","volume":"4","author":"Aversa","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1080\/14653240802251507_bib0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med"},{"key":"10.1080\/14653240802251507_bib0060","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-199805270-00017","article-title":"Tolerance induction by \u2018megadose\u2019 hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture","volume":"65","author":"Rachamim","year":"1998","journal-title":"Transplantation"},{"key":"10.1080\/14653240802251507_bib0065","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood.V99.11.4174","article-title":"Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells","volume":"99","author":"Gur","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0070","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u2018three-loci\u2019 incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0075","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240802251507_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1701228","article-title":"Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting","volume":"21","author":"Handgretinger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/106161299320488","article-title":"Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device","volume":"8","author":"Schumm","year":"1999","journal-title":"J Hematother"},{"key":"10.1080\/14653240802251507_bib0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0095","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240802251507_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bcmd.2004.08.006","article-title":"Canadian multicenter pilot trial of haploidentical donor transplantation","volume":"33","author":"Walker","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1080\/14653240802251507_bib0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1703649","article-title":"Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors","volume":"30","author":"Redei","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0110","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.leu.2401577","article-title":"Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment","volume":"13","author":"Peters","year":"1999","journal-title":"Leukemia"},{"key":"10.1080\/14653240802251507_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bmt.1704342","article-title":"Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies","volume":"33","author":"Yamasaki","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bmt.1704900","article-title":"Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution","volume":"35","author":"Kim","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.semcancer.2006.07.007","article-title":"Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation","volume":"16","author":"Ruggeri","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1080\/14653240802251507_bib0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1471-4906(02)02284-6","article-title":"NK cells: a lesson from mismatched hematopoietic transplantation","volume":"23","author":"Velardi","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1080\/14653240802251507_bib0135","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1080\/14653240802251507_bib0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1080\/14653240802251507_bib0150","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1080\/14653240802251507_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1703619","article-title":"A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells","volume":"30","author":"Gordon","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14653240310004411","article-title":"A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation","volume":"6","author":"Barfield","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240802251507_bib0165","first-page":"2910","article-title":"Haploidentical stem cell transplantation with CD3 depleted mobilized peripheral blood stem cell grafts for children with hematologic malignancies","volume":"106","author":"Hale","year":"2005","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1080\/14653240802251507_bib0170","first-page":"3137","article-title":"Mismatched family member donor transplantation for patients with refractory hematologic malignancies: long-term followup of a prospective clinical trial","volume":"108","author":"Hale","year":"2006","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1080\/14653240802251507_bib0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2006.06330.x","article-title":"Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies","volume":"135","author":"Chen","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1080\/14653240802251507_bib0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1392.022","article-title":"Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation","volume":"1106","author":"Handgretinger","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1080\/14653240802251507_bib0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cell Mol Dis"},{"key":"10.1080\/14653240802251507_bib0190","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240802251507_bib0195","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","article-title":"Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution","volume":"25","author":"Rizzieri","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1080\/14653240802251507_bib0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2006.06.007","article-title":"Unmanipulated HLA 2\u20133 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning","volume":"12","author":"Ogawa","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 9","key":"10.1080\/14653240802251507_bib0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.TP.0000067948.90241.82","article-title":"Tolerance and chimerism","volume":"75","author":"Kolb","year":"2003","journal-title":"Transplantation"},{"key":"10.1080\/14653240802251507_bib0220","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/pbc.21376","article-title":"Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9\/ETV6 rearrangement","volume":"50","author":"Hauer","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1080\/14653240802251507_bib0225","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V99.5.1572","article-title":"Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling","volume":"99","author":"van Rood","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0230","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1704692","article-title":"Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance","volume":"34","author":"Obama","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.coi.2005.07.009","article-title":"Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation","volume":"17","author":"Ichinohe","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1080\/14653240802251507_bib0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bmt.1705616","article-title":"Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?","volume":"39","author":"Cashen","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0245","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","article-title":"Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors","volume":"174","author":"Leung","year":"2005","journal-title":"J Immunol"},{"key":"10.1080\/14653240802251507_bib0250","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-01-135285","article-title":"Survival after T-cell depleted haploidentical stem cell transplantation is improved using the mother as donor","author":"Stern","year":"2008","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0255","first-page":"2907","article-title":"Risk factors of HLA-haploidentical transplantation using the combination of unmodified marrow and CD6-depleted G-CSF mobilized blood cells","volume":"106","author":"Kolb","year":"2005","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1080\/14653240802251507_bib0260","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14653240701644000","article-title":"A large-scale method for the selective depletion of alpha\/beta T lymphocytes from PBSC for allogeneic transplantation","volume":"9","author":"Chaleff","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240802251507_bib0265","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00262-005-0094-6","article-title":"Characterization of the gamma\/delta T cell response to acute leukemia","volume":"55","author":"Meeh","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1080\/14653240802251507_bib0270","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gamma\/delta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1080\/14653240802251507_bib0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157488808784223023","article-title":"Molecular monitoring of immune reconstitution after haploidentical stem cell transplantation","volume":"3","author":"Chen","year":"2008","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1080\/14653240802251507_bib0280","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0285","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood-2004-04-1405","article-title":"Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"105","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2004.04.001","article-title":"Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement","volume":"19","author":"Wils","year":"2005","journal-title":"Blood Rev"},{"key":"10.1080\/14653240802251507_bib0295","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0300","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/CJI.0b013e31815ef862","article-title":"Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation","volume":"31","author":"Feuchtinger","year":"2008","journal-title":"J Immunother"},{"key":"10.1080\/14653240802251507_bib0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2007.07.002","article-title":"CMV-specific T cell therapy","volume":"40","author":"Einsele","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1080\/14653240802251507_bib0310","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","article-title":"Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus","volume":"107","author":"Beck","year":"2006","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0315","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0320","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/sj.leu.2402552","article-title":"Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL","volume":"16","author":"Bader","year":"2002","journal-title":"Leukemia"},{"key":"10.1080\/14653240802251507_bib0325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.patbio.2004.03.010","article-title":"Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia","volume":"53","author":"Klingebiel","year":"2005","journal-title":"Pathol Biol (Paris)"},{"key":"10.1080\/14653240802251507_bib0330","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ni1580","article-title":"Natural killer cell-directed therapies: moving from unexpected results to successful strategies","volume":"9","author":"Terme","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1080\/14653240802251507_bib0335","article-title":"Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia: feasibility and safety study","author":"Huang","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1080\/14653240802251507_bib0340","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncponc0848","article-title":"Experimental and clinical approaches for optimization of the graft-versus-leukemia effect","volume":"4","author":"Sprangers","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1080\/14653240802251507_bib0345","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2003-05-1735","article-title":"Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts","volume":"103","author":"Lang","year":"2004","journal-title":"Blood"},{"key":"10.1080\/14653240802251507_bib0350","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.bmt.1705676","article-title":"Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation","volume":"39","author":"Schumm","year":"2007","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532490870197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532490870197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:12:06Z","timestamp":1761430326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532490870197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"alternative-id":["S146532490870197X"],"URL":"https:\/\/doi.org\/10.1080\/14653240802251507","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The history and future prospective of haplo-identical stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240802251507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}